UnitedHealth Group Incorporated (NYSE:UNH) Holdings Trimmed by Faithward Advisors LLC

Faithward Advisors LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 13.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,832 shares of the healthcare conglomerate’s stock after selling 424 shares during the quarter. Faithward Advisors LLC’s holdings in UnitedHealth Group were worth $1,433,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Tandem Investment Partners LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $581,000. APG Asset Management N.V. lifted its holdings in shares of UnitedHealth Group by 440.4% in the fourth quarter. APG Asset Management N.V. now owns 886,446 shares of the healthcare conglomerate’s stock valued at $433,044,000 after purchasing an additional 722,421 shares in the last quarter. Bernard Wealth Management Corp. acquired a new position in UnitedHealth Group during the fourth quarter valued at $1,253,000. Renaissance Technologies LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $140,962,000. Finally, Bank of Nova Scotia boosted its holdings in shares of UnitedHealth Group by 119.4% during the fourth quarter. Bank of Nova Scotia now owns 635,455 shares of the healthcare conglomerate’s stock worth $321,489,000 after purchasing an additional 345,799 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on UNH. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Down 0.1 %

NYSE UNH opened at $524.56 on Tuesday. The firm has a 50-day simple moving average of $508.87 and a 200 day simple moving average of $541.48. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $479.82 billion, a PE ratio of 33.84, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.